Multidimensional Comparison of Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children, a 12-Week, Open-Label, Head-to-Head Clinical Trial
Psychiatry Investigation · 25.02.2025 · 22 (2) · 140-147
DOI: 10.30773/pi.2024.0204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry Investigation, erschienen am 25.02.2025. Verfasst von Lin Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Health, Tangshan Maternal and Child Health Hospital, North China University of Science and Technology, Hebei Tangshan, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
To compare the treatment efficacy of methylphenidate and atomoxetine on core symptoms, behavioral and emotional problems, and executive function in children with attention-deficit/hyperactivity disorder (ADHD).
Methods
Sixty children with ADHD diagnosed by the fifth edition Diagnostic and Statistical Manual of Mental Disorders in Tangshan Maternal and Child Health Hospital from 2023 to 2024 were randomly divided into methylphenidate and atomoxetine groups. Core symptoms were assessed using the Parent Swanson, Nolan, and Pelham, Version IV Scale (SNAP-IV) and Integrated Visual and Auditory Continuous Performance Test (IVA-CPT). Behavioral and emotional problems were administered via the Conners Parent Symptom Questionnaire (PSQ) and executive function was evaluated utilizing the Wisconsin Card Sorting Test (WCST) and Digit Span Test (DST). All data were analyzed using SPSS 26.00 to identify discrepancies.
Results
When contrasted with the methylphenidate and atomoxetine groups at 12 weeks, their mean efficiency was no significant disparity (p>0.05). Notable statistical differences were evident in IVA-CPT, the inattention, hyperactivity-impulsivity of SNAP-IV, and the psychosomatic disorder, anxiety, and hyperactivity-impulsivity of PSQ (p0.05). No statistical significance was attributed to DST and the number of completed categories in WCST (p>0.05) but to response errors and perseverative errors (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Child Health, Tangshan Maternal and Child Health Hospital, North China University of Science and Technology, Hebei Tangshan, China.
Zitieren
APA
Chen, L., & Du, W. (2025). Multidimensional Comparison of Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children, a 12-Week, Open-Label, Head-to-Head Clinical Trial. Psychiatry Investigation, 22(2), 140-147. https://doi.org/10.30773/pi.2024.0204
Vancouver
Chen L, Du W. Multidimensional Comparison of Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children, a 12-Week, Open-Label, Head-to-Head Clinical Trial. Psychiatry Investigation. 2025;22(2):140-147. doi:10.30773/pi.2024.0204
BibTeX
@article{Chen2025,
author = {Chen, Lin and Du, Wenran},
title = {Multidimensional Comparison of Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children, a 12-Week, Open-Label, Head-to-Head Clinical Trial},
journal = {Psychiatry Investigation},
year = {2025},
volume = {22},
number = {2},
pages = {140--147},
doi = {10.30773/pi.2024.0204}
}
EUVIMED